Navigation Links
Natural gut hormone offers hope for new obesity drug

A hormone found naturally in the gut is the basis of a new drug to tackle obesity, one of three inaugural awards under the Wellcome Trust's Seeding Drug Discovery initiative. The drug is being developed by one of the world's leading obesity experts, Professor Steve Bloom at Imperial College London's Hammersmith Hospital campus.

"Over 30,000 deaths a year are caused by obesity in England alone, so there is a clear need to develop a treatment to tackle this problem," says Dr Ted Bianco, Director of Technology Transfer at the Wellcome Trust. "Yet this need for effective anti-obesity therapies is currently unmet. We believe that Professor Bloom's research holds great promise and, with our support, can be translated into tangible benefits to health."

Recent research by Professor Bloom and his team identified the role played by gut hormones in appetite control. These hormones are released when a person eats, acting as neurotransmitters to indicate to the brain to stop eating. In particular, the researchers are interested in pancreatic polypeptide (PP), which they believe may provide a solution to appetite suppression and is the most likely candidate for translating into a treatment.

"Developing a treatment based on natural appetite suppression, mimicking our body's response to being full, has the potential to be safe and effective," says Professor Bloom. "We believe that pancreatic polypeptide may be the answer."

Professor Bloom points to research showing that people with benign PP-secreting tumours have elevated levels of the hormone and yet appear to show no adverse side-effects.

"These people may have had high levels of PP for ten or fifteen years without showing side effects," he explains. "In that sense, they have provided us with a natural experiment that suggests that excess levels of PP over a long period are safe. It does not appear to raise blood pressure or heart rate, or any other obvious side effects."

Wit h funding from the Seeding Drug Discovery initiative, Professor Bloom and colleague Dr Caroline Small hope to develop a synthetic form of PP which can be administered to patients.

"The trouble with PP is that it would need to be injected daily and cannot be taken as a pill," says Dr Small. "Naturally, this is not very convenient, so we need to develop an injectable form that is longer lasting and can be administered on a weekly basis to make it more practical."

If successful, the proposed research may lead to a treatment within five to eight years.

"It is likely that if we are successful, the treatment may be fast tracked to meet the urgent demand to tackle the obesity crisis," she explains. "There is currently a lack of effective treatments and our proposed drug is based on a natural way of controlling the body's appetite, which makes it more attractive."


'"/>

Source:Wellcome Trust


Related biology news :

1. Genetically Modified Natural Killer Immune Cells Attack, Kill Leukemia Cells
2. Natural Killers Could Lead to New Hepatitis Treatments
3. Natural tumor suppressor in body discovered by UCSD medical researchers
4. Naturally occurring asbestos linked to lung cancer
5. Natural compound from pond scum shows potential activity against Alzheimers
6. Natural selection at single gene demonstrated
7. Natural vitamin E tocotrienol reaches blood at protective levels
8. Natural pine bark extract relieves muscle cramp and pain in athletes and diabetics
9. Natural protein stops deadly human brain cancer in mice
10. Natural anti-viral enzyme helps keep cancer cells alive, researchers find
11. Natural polyester makes new sutures stronger, safer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2018)... ... November 15, 2018 , ... Firmex today released new research ... surveyed over 480 investment bankers and M&A advisors worldwide to compile the third annual ... on the key findings in the report. , Highlights in the 2018-19 Report:, ...
(Date:11/15/2018)... YORK (PRWEB) , ... November 14, 2018 , ... ... Sinai have developed a tool that speeds up the analysis and publication of ... researchers communicate results of their studies. Until now, the primary method available to ...
(Date:11/15/2018)... ... November 14, 2018 , ... ... lab, will present new scientific evidence on gene-disease relationships and how it supports ... to be held in Atlanta, November 14-17. , Ambry has been selected ...
Breaking Biology News(10 mins):
(Date:10/18/2018)... HAYWARD, Calif. (PRWEB) , ... October 18, 2018 ... ... its CLIA-certified genomic sequencing laboratory in the San Francisco Bay Area has received ... in quality, operations, and patient safety. , Predicine received CAP accreditation for its ...
(Date:10/17/2018)... ... October 17, 2018 , ... ... and his associate, Dr. Michael Kang, are offering current and new patients the ... results thanks to the emerging, proven treatment technology known as Piezosurgery® . ...
(Date:10/17/2018)... ... 2018 , ... PathSensors’ cutting-edge CANARY based assays for the ... and Plant Health Inspection Service for use in regulatory diagnostics. By going through ... they will be able to rapidly and accurately test and identify these damaging ...
(Date:10/16/2018)... ... October 16, 2018 , ... Infinity ... Congressional briefing on a revolutionary technology that effectively treats pain, reduces the need ... Healing, testified on how technology using photobiomodulation (PBM) has been effective for the ...
Breaking Biology Technology: